Concepedia

Ilaria Gnemmi

IG

Statistics

Publications

4

Citations

230

H-Index

4

Active since

2007

Affiliations

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”(Current)

University College London

Ilaria Gnemmi is an author at Università degli Studi del Piemonte Orientale “Amedeo Avogadro” specializing in oncology, pharmacology, and medicine.

Publications per year

2007–2016

4

Publications

4

EXPRESSION OF CONCERN: Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells

Fabrizio Condorelli, Ilaria Gnemmi, Antonella Vallario et al. · British Journal of Pharmacology · 2007 · 122 citations · Full text

Medicine, Oncology, Pharmacology +17

Nicotinamide phosphoribosyltransferase (<scp>NAMPT</scp>/<scp>PBEF</scp>/visfatin) is a tumoural cytokine released from melanoma

Ambra A. Grolla, Simone Torretta, Ilaria Gnemmi et al. · Pigment Cell & Melanoma Research · 2015 · 70 citations

Life Sciences, Immunology, Oncology +15

A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma

Francesco Sottile, Ilaria Gnemmi, Sandra Cantilena et al. · Oncotarget · 2012 · 20 citations · Full text

Medicine, Oncology, Pharmacology +16

Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2

Beatrice Riva, Marco De Dominici, Ilaria Gnemmi et al. · Oncotarget · 2016 · 18 citations · Full text

Medicine, Oncology, Pharmacology +16

1–4 of 4